Utilization of redox modulating small molecules that selectively act as pro-oxidants in cancer cells to open a therapeutic window for improving cancer therapy

There is a rapidly growing body of literature supporting the notion that differential oxidative metabolism in cancer versus normal cells represents a metabolic frailty that can be exploited to open a therapeutic window into cancer therapy. These cancer cell-specific metabolic frailties may be amenab...

Descripción completa

Detalles Bibliográficos
Autores principales: Petronek, M.S., Stolwijk, J.M., Murray, S.D., Steinbach, E.J., Zakharia, Y., Buettner, G.R., Spitz, D.R., Allen, B.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Articles from the Special Issue on Redox Modulation of Cancer Heterogeneity, Therapeutic Resistance and Immunotherapy Efficacy; Edited by Dr. Anita Hjelmeland
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113052/
https://www.ncbi.nlm.nih.gov/pubmed/33485837
http://dx.doi.org/10.1016/j.redox.2021.101864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113052/
https://www.ncbi.nlm.nih.gov/pubmed/33485837
http://dx.doi.org/10.1016/j.redox.2021.101864

Ejemplares similares